Navigation Links
Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance
Date:1/15/2008

NEW YORK, Jan. 15 /PRNewswire/ -- As drastic cutbacks at major pharmaceuticals continue, competition soars from generics and challenge blockbuster drug teams. Social networks have entered the zone of physician and patient encounters. Advertising expenditures are being scrutinized for ROI. Product recalls and drug safety warnings pose new issues and responsibilities on drug marketers. Yet new marketing opportunities have opened up with the growth of multicultural segments, new technologies, media channels and sales force optimization tools.

This year's 2nd Annual Pharmaceutical Sales & Marketing Executive Congress, scheduled for March 31 - April 1, 2008 in Bethesda, Maryland brings together an impressive line-up of experts and industry leaders who will outline trends, case studies, and best-practices required to reformulate pharmaceutical marketing and sales strategies in the light of the new rules of engagement in this industry. Speaking faculty includes:

-- Hon. Gene Green (D-TX), Member, Health Subcommittee - Energy & Commerce

Committee, U. S. House of Representatives

-- Paul J. Savidge, VP, Global Labeling & Compliance, Bristol-Myers Squibb

-- Liliana A. Gil, Worldwide Director of Marketing Services & Hispanic

Strategy Lead, Johnson & Johnson

-- Ellen Shapiro, Director, Division of Communications, Center for Drug

Evaluation and Research (CDER), FDA

-- David Lampinski, Associate Director, Commercial Analytics, Sepracor

Inc.

-- Jeannie Miller, Managed Markets, Jazz Pharmaceuticals

-- Glenn Byrd, VP, Regulatory Affairs, MedImmune

-- Chris Bogan, CEO, Best Practices LLC

-- John Mack, Publisher, Pharma Marketing News

-- Robin L. Winter-Sperry, M.D., President & CEO, Scientific Advantage

-- Nayan Shah M.D., Associate Professor of Medicine, Georgetown University

Medical Center

-- Hugo Stephenson, M.D., President, iGuard.Org

-- Jan Malek, Director, IDSG-Life Sciences, Cisco Systems

-- John S. Lenart, Senior Brand Director, Arestin(R), OraPharma, Inc.

-- Ilyssa Levins, President, Center for Communication Compliance and HCIL

Healthcare Consulting

-- Harry Sweeney, Chairman and CEO, Dorland Global Health Communications

Group

-- Kathy Kastner, CEO, The Health Television System

-- Ed Silverman, Founder, Pharmalot & Award-Winning Journalist, New Jersey

Star Ledger

-- Mark Bard, President, Manhattan Research

For Complete List of Speakers, Detailed Agenda, and to Register: http://www.iibig.com/P0802

Call: 212-300-2523

E-mail: rial@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
2. Out beyond the horizon
3. Out beyond the horizon
4. SAFC Pharma to Increase Viral Product Manufacturing Capacity
5. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
6. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
7. Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division
8. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
9. ViroPharma Provides 2008 Outlook
10. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
11. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Ithaca, NY (PRWEB) , ... January 20, 2017 , ... ... of a Joint Venture (JV) under which Nipro will receive exclusive marketing and sales ... decade to establish best practices for hemodialysis patients in Japan, the new Nipro - ...
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, ... the "Company"), announced that on January 14, 2017 the ... under which the Company will terminate certain employees associated ... Diagnostics, Inc.  The Company commenced terminations on January 16, ... 30 days.  The Company may pay severance benefits in ...
(Date:1/20/2017)... PA (PRWEB) , ... January 20, 2017 , ... The ... transforming healthcare treatment options for patients. Vironika, a spin out from The Wistar Institute, ... both taking lab space at 3624 Market Street. , Vironika is developing a ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
Breaking Biology Technology:
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
(Date:1/11/2017)... MOINES, Iowa , Jan. 11, 2017 ... industry first with the release of its patent-pending calibration ... quickly and reliably perform calibrations, securely upload data logs ... flexibility for the customer. "Fighting drunk driving ... only for the public at large, but also for ...
(Date:1/6/2017)... Colo. , Jan. 5, 2017  SomaLogic ... the "Digital Life Alliance" established by iCarbonX, the ... 2015 to build a "Global Digital Health Ecosystem ... on a combination of individual,s biological, behavioral and ... the agreement between the companies, SomaLogic will provide ...
Breaking Biology News(10 mins):